Author: Mamtani, M.; Athavale, A. M.; Abraham, M.; Vernik, J.; Amarah, A. R.; Ruiz, J. P.; Joshi, A. J.; Itteera, M.; Zhukovski, S. D.; Madaiah, R. P.; White, B. C.; Hart, P.; Kulkarni, H.
Title: ASSOCIATION OF HYPERGLYCAEMIA WITH HOSPITAL MORTALITY IN NONDIABETIC COVID-19 PATIENTS: A COHORT STUDY Cord-id: ouk9sho2 Document date: 2021_3_26
ID: ouk9sho2
Snippet: Objective Diabetes is a known risk factor for mortality in Coronavirus disease 2019 (COVID-19) patients. Our objective was to identify prevalence of hyperglycaemia in COVID-19 patients with and without prior diabetes and quantify its association with COVID-19 disease course. Research Design and Methods This observational cohort study included all consecutive COVID-19 patients admitted to John H Stroger Jr. Hospital, Chicago, IL from March 15, 2020 to May 3, 2020 and followed till May 15, 2020. T
Document: Objective Diabetes is a known risk factor for mortality in Coronavirus disease 2019 (COVID-19) patients. Our objective was to identify prevalence of hyperglycaemia in COVID-19 patients with and without prior diabetes and quantify its association with COVID-19 disease course. Research Design and Methods This observational cohort study included all consecutive COVID-19 patients admitted to John H Stroger Jr. Hospital, Chicago, IL from March 15, 2020 to May 3, 2020 and followed till May 15, 2020. The primary outcome was hospital mortality, and the studied predictor was hyperglycaemia [any blood glucose ≥ 7.78 mmol/L (140 mg/dL) during hospitalization]. Results Of the 403 COVID-19 patients studied, 51 (12.7%) died; 335 (83.1%) were discharged while 17 (4%) were still in hospital. Hyperglycaemia occurred in 228 (56.6%) patients; 83 of these hyperglycaemic patients (36.4%) had no prior history of diabetes. Compared to the reference group no-diabetes / no-hyperglycaemia patients the no-diabetes / hyperglycaemia patients showed higher mortality [1.8% versus 20.5%, adjusted odds ratio 21.94 (95% confidence interval 4.04-119.0), P < 0.001]; improved prediction of death (P = 0.01) and faster progression to death (P < 0.01). Hyperglycaemia within the first 24 and 48 hours was also significantly associated with mortality (odds ratio 2.15 and 3.31, respectively). Conclusions Hyperglycaemia without prior diabetes was common (20.6% of hospitalized COVID-19 patients) and was associated with an increased risk of and faster progression to death. Development of hyperglycaemia in COVID-19 patients who do not have diabetes is an early indicator of progressive disease.
Search related documents:
Co phrase search for related documents- absolute relative and additional analysis: 1
- absolute relative and admission time: 1, 2
- absolute relative and liver disease: 1
- absolute relative and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9
- absolute relative and logistic regression model: 1, 2, 3
- absolute relative and lung disease: 1, 2, 3
- absolute relative and lymphocyte count: 1, 2
- acute disease respiratory distress syndrome and additional analysis: 1
- acute disease respiratory distress syndrome and admission illness severity: 1
- acute disease respiratory distress syndrome and admission time: 1, 2, 3, 4, 5, 6
- acute disease respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6
- acute disease respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute disease respiratory distress syndrome and logistic regression analysis: 1, 2, 3, 4
- acute disease respiratory distress syndrome and logistic regression model: 1, 2, 3
- acute disease respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
- acute disease respiratory distress syndrome and lung pathology: 1, 2, 3, 4, 5, 6
- acute disease respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute disease respiratory distress syndrome and macrophage activation: 1, 2, 3
- acute disease respiratory distress syndrome and macrophage activation syndrome: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date